Winning the Battle, Losing the War: The Noncurative “Curative” Resection for Stage I Adenocarcinoma of the Lung

This publication has 22 references indexed in Scilit:

• Gene Profiling of Clinical Routine Biopsies and Prediction of Survival in Non–Small Cell Lung Cancer
  American Journal of Respiratory and Critical Care Medicine, 2010
• Early Recurrence after Surgical Resection in Patients with Pathological Stage I Non-small Cell Lung Cancer
  The Thoracic and Cardiovascular Surgeon, 2009
• A Clinical Model to Estimate Recurrence Risk in Resected Stage I Non-Small Cell Lung Cancer
  American Journal of Clinical Oncology, 2008
• Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
  The Lancet Oncology, 2006
• A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
  New England Journal of Medicine, 2004
• Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2004
• Breaking down barriers: Helpful breakthrough statistical methods you need to understand better
  The Journal of Thoracic and Cardiovascular Surgery, 2001
• Bagging predictors
  Machine Learning, 1996
• Outcome analysis using hazard function methodology
  The Annals of Thoracic Surgery, 1996
• The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information
  Journal of the American Statistical Association, 1986